Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology
Reference45 articles.
1. Centers for Disease Control and Prevention. HIV surveillance report, 2018 (updated). Available from: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Accessed 30 Sep 2021.
2. Huang YA, Zhu WK, Smith DW, Harris N, Hoover K. HIV preexposure prophylaxis, by race and ethnicity—United States, 2014–2016. MMWR Morb Mortal Wkly Rep. 2018;67(41):1147–50.
3. Bush S, Rawlings K, Magnuson D, Martin P, Lugo-Torres O, Mera-Giler R. Utilization of emtricitabine/tenofovir (FTC/TDF) for HIV pre-exposure prophylaxis in the United States by gender (2013–1Q2016) International Congress of Drug Therapy in HIV Infection. Glasgow, UK. Abs O314. 2016
4. Theodore DA, Zucker J, Carnevale C, et al. Pre-exposure prophylaxis use among predominantly African American and Hispanic women at risk for HIV acquisition in New York City. J Assoc Nurses AIDS Care. 2020;31(1):110–4.
5. Blackstock OJ, Patel VV, Felsen U, Park C, Jain S. Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic. AIDS Care. 2017;29(7):866–9.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献